President Donald Trump speaks speaks on the latest developments of the coronavirus outbreak, while flanked by White House coronavirus response coordinator Debbie Birx (L), and U.S. Surgeon General Jerome Adams (R), in the James Brady Press Briefing Room at the White House March 19, 2020. (Photo by Chip Somodevilla/Getty Images)
President Donald Trump in a press conference on Thursday said the Food and Drug Administration is fast-tracking efforts to approve an antiviral therapy, best known for treating malaria, for use in coronavirus cases.
The drug, hydroxychloroquine, was developed more than a half-century ago and is approved for treating malaria, arthritis, and other ailments. Reports out of China and Italy suggest the drug may help, but there is no hard data yet.
"We're going to be able to make that drug available almost immediately," Trump said.
The FDA is working to conduct a "large, pragmatic clinical trial" quickly to confirm the drug's benefit to coronavirus patients, said Commissioner Dr. Stephen Hahn.
He also tempered the president's optimism about the still-untested solution.
"What's also important is not to provide false hope," he said. "We may have the right drug, but it might not be in the appropriate dosage form right now, and it might do more harm than good."
New antiviral therapies face a shorter and less arduous approval process than vaccines, several of which are under development with 12 to 18-month timelines.
"The therapies are something we could move on much faster potentially," Trump said.
He claimed the administration "slashed red tape" to develop new vaccines and therapies.
The president also held out on confirming whether he would invoke the Defense Production Act, which he signed on Wednesday, to mandate the production of needed medical supplies such as N95 respirators and surgical masks.
"If we find that we need something, then we will do that," he said.
Trump repeated that he was open to the federal government buying equity stakes in the airline, cruise, hospitality, and other industries hurt by the outbreak.
The press conference opened with more controversial language placing the blame squarely on China for the outbreak, despite concerns voiced about potentially exacerbating a backlash against Asian Americans.
"We continue our relentless effort to defeat the Chinese virus," Trump said.
Back in 2010, several large companies pledged to work towards stopping deforestation by 2020. Companies like Nestle and Carrefour even went further to say that they would eliminate deforestation from their supply chains altogether. However, fast forward to 2020, many of these companies have failed to reach that goal. Associate Director of Forest at the CDP Nadia Bishai, joined Cheddar to discuss more.
Instagram Chief Executive Adam Mosseri is set to testify before Congress for the first time. Mosseri’s appearance follows reports that showed Facebook and Instagram are aware of the harms their apps and services cause, including to teen mental health. Nicole Gill, co-founder and executive director of Accountable Tech joins Cheddar News to preview the hearing.
Chamber of Progress CEO Adam Kovacevich joined Wake Up With Cheddar to break down what to expect from the cryptocurrency executives appearing on Capitol Hill and how it could impact future crypto regulation. "I think what most people want to see from regulation is essentially channeling the good and the potential and putting in place guardrails to minimize the bad," he said.
Markets opened higher as investors shrugged off weaker-than-expected job growth and Omicron fears. George Seay, CEO, Annandale Capital joined Cheddar's Opening Bell to discuss.
Less than six months after making its public debut on the NYSE, Chinese ride-hailing giant Didi says it will delist in the U.S. and pivot to Hong Kong instead. Chinese regulators are citing cybersecurity and data concerns. Shehzad Qazi, Managing Director, China Beige Book International joined Cheddar's Opening Bell to discuss.
While the World Health Organization strongly advises against a COVID-19 vaccine mandate, national and local governments are moving to make inoculations compulsory. Cheddar News speaks with Dr. Joel Zinberg of the Competitive Enterprise Institute on the issue.
